Stay updated with breaking news from Resure sealant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Paradigm Capital Management Inc. NY grew its holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 100.0% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 80,000 shares of the biopharmaceutical company’s stock after buying an additional 40,000 shares during the quarter. […] ....
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) General Counsel Philip C. Strassburger sold 6,831 shares of the firm’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $4.95, for a total transaction of $33,813.45. Following the transaction, the general counsel now directly owns 109,218 […] ....
Ocular Therapeutix, Inc. (NASDAQ:OCUL) CFO Donald Notman Sells 6,433 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ocular Therapeutix, Inc. (NASDAQ:OCUL) General Counsel Philip C. Strassburger Sells 6,831 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Philip C. Strassburger Sells 6,831 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.